{"id":"W2171046634","doi":"10.1158/1078-0432.ccr-08-0761","title":"Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Oxaliplatin; Pharmacokinetics; Tolerability; FOLFOX; Internal medicine; Colorectal cancer; Fluorouracil; Regimen; Dosing; Pharmacology; Oncology; Phases of clinical research; Gastroenterology; Toxicity; Chemotherapy; Cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000635799,0.0001492225,0.0005590753,0.0002159296,0.00007436672,0.0000100764,0.0000704085,0.00006874369,0.00006528322],"category_scores_gemma":[0.0001723839,0.00009787278,0.00002404711,0.0007227762,0.0002292188,0.0001023445,0.00005457605,0.0005176234,4.82414e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003015497,"about_ca_system_score_gemma":0.0003415453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001384917,"about_ca_topic_score_gemma":0.009040262,"domain_scores_codex":[0.9977536,0.0001857778,0.0004966448,0.0004236363,0.0008221365,0.0003182614],"domain_scores_gemma":[0.9987828,0.0003485852,0.0001019211,0.0001377593,0.0005060837,0.0001229062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03265542,0.010973,0.8224384,0.00002763195,0.00005961955,0.00003352272,0.001030616,0.00001525881,0.00004005452,0.00001022598,0.00002947405,0.1326867],"study_design_scores_gemma":[0.06211546,0.05320027,0.8834211,0.0002972505,0.00002914302,4.826388e-7,0.0006518127,0.00005912931,0.00006342233,0.00003257868,0.00003455445,0.00009477813],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966379,0.0004816473,4.041646e-7,0.0005641594,0.00003848349,0.001922889,0.00002192046,0.000009011694,0.0003235956],"genre_scores_gemma":[0.9991042,0.0003800142,0.00004779833,0.0000572758,0.00003230657,0.0003078181,0.00001219132,0.00001212166,0.00004625647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1325919,"threshold_uncertainty_score":0.5044678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08583454801042077,"score_gpt":0.485112590518211,"score_spread":0.3992780425077903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}